Journal of Viral Hepatitis

© John Wiley & Sons Ltd

Cover image for Vol. 19 Issue 7

July 2012

Volume 19, Issue 7

Pages 449–524

  1. REVIEW ARTICLE

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
    1. Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents (pages 449–464)

      F. Poordad and D. Dieterich

      Article first published online: 7 JUN 2012 | DOI: 10.1111/j.1365-2893.2012.01617.x

  2. ORIGINAL ARTICLES

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
    1. Methylenetetrahydrofolate reductase homozygosis and low-density lipoproteins in patients with genotype 1 chronic hepatitis C (pages 465–472)

      S. Petta, C. Bellia, A. Mazzola, D. Cabibi, C. Cammà, A. Caruso, V. Di Marco, A. Craxì and M. Ciaccio

      Article first published online: 28 NOV 2011 | DOI: 10.1111/j.1365-2893.2011.01557.x

    2. Role of Helicobacter pylori in patients with HCV-related chronic hepatitis and cirrhosis with or without hepatocellular carcinoma: possible association with disease progression (pages 473–479)

      G. Esmat, M. El-Bendary, S. Zakarya, M. A. Ela and K. Zalata

      Article first published online: 28 DEC 2011 | DOI: 10.1111/j.1365-2893.2011.01567.x

    3. Assessment of factors associated with pre-diabetes in HCV infection including direct and dynamic measurements of insulin action (pages 480–487)

      N. A. Mukhtar, C. Ayala, J. J. Maher and M. Khalili

      Article first published online: 18 DEC 2011 | DOI: 10.1111/j.1365-2893.2011.01568.x

    4. The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1–infected patients treated with Peg-IFN-alfa-2a and ribavirin (pages 488–496)

      H. Guedj, J. Guedj, F. Negro, M. Lagging, J. Westin, P.-Y. Bochud, S. Bibert and A. U. Neumann, for the DITTO-HCV study group

      Article first published online: 22 DEC 2011 | DOI: 10.1111/j.1365-2893.2011.01569.x

    5. Evolution of biomarkers of liver fibrosis and liver insufficiency in hepatitis C virus-infected patients treated with pegylated interferon plus ribavirin and rituximab (pages 497–500)

      G. Geri, B. Terrier, F. Imbert-Bismut, D. Saadoun, D. Sène, T. Poynard and P. Cacoub

      Article first published online: 3 JAN 2012 | DOI: 10.1111/j.1365-2893.2011.01571.x

    6. Cytokine profiles in high risk injection drug users suggests innate as opposed to adaptive immunity in apparent resistance to hepatitis C virus infection (pages 501–508)

      U. M. Warshow, A. Riva, D. Hegazy, P. H. Thurairajah, E.R. Kaminski, S. Chokshi and M. E. Cramp

      Article first published online: 4 JAN 2012 | DOI: 10.1111/j.1365-2893.2011.01574.x

    7. Role of monokine induced by interferon-γ in liver injury induced by hepatitis B virus in mice (pages 509–518)

      Y. J. Xia, D. Zeng, L. M. Xia, F. Yu, H. H. Lin, L. Zhou, D. A. Tian and M. Liu

      Article first published online: 28 JAN 2012 | DOI: 10.1111/j.1365-2893.2011.01581.x

    8. Maternal HBsAg status and infant size – a Faustian bargain? (pages 519–524)

      T. T. Lao, D. S. Sahota, S. S. H. Suen, L. W. Law and T. Y. Leung

      Article first published online: 28 JAN 2012 | DOI: 10.1111/j.1365-2893.2011.01575.x

SEARCH

SEARCH BY CITATION